+44 3455007136  |  contact@probejournals.com
Follow us:

Journal of Diseases

Home > Journals > Journal of Diseases
Journal of Diseases
Journal Cite Score: 2.91
Journal Impact Factor: 2.11
Overall acceptance and publication time: 07-25 days
Average article processing time: 10-20 days
Journal H-Index: 5
Please submit article at: publish@probejournals.com

Our Editors

Dr. Shrikant Charde

Dr. Shrikant Charde

Editor in Chief
Vice President, Department of Clinical Pharmacology, Allucent, Cary, United States
Dr. Yang I. Pachankis

Dr. Yang I. Pachankis

Editor
Universal Life Church, Communication University of China, Beijing, China
Dr. Xudong Zhu

Dr. Xudong Zhu

Editor
Department of General Surgery, Cancer Hospital of China Medical University, China

Aim and scope

Journal of Diseases is an international, peer-reviewed, open-access journal dedicated to publishing high-quality research that advances the understanding, prevention, diagnosis, treatment, and management of human diseases. The journal provides a multidisciplinary platform for researchers, clinicians, healthcare professionals, and public health experts to disseminate original scientific findings that contribute to improved patient care and global health.

The journal welcomes Original Research Articles, Review Articles, Systematic Reviews and Meta-Analyses, Short Communications, Case Reports (where appropriate), Clinical Studies, Technical Notes, Perspectives, and Editorials. Through a rigorous peer-review process and adherence to the highest standards of publication ethics, the Journal of Diseases aims to promote scientific excellence, innovation, and evidence-based medical practice.

The Journal of Diseases aims to advance scientific knowledge in disease research by publishing innovative, high-quality studies that improve the understanding of disease mechanisms, epidemiology, diagnosis, prevention, treatment, and patient outcomes. The journal encourages interdisciplinary research that bridges basic science, translational medicine, clinical practice, and public health to address current and emerging health challenges worldwide.

The Journal of Diseases publishes research across all major areas of disease and health sciences. The journal welcomes interdisciplinary studies that contribute to the prevention, diagnosis, management, and treatment of diseases. Areas of interest include, but are not limited to:

Infectious Diseases
Emerging and Re-emerging Diseases
Chronic Diseases
Cardiovascular Diseases
Respiratory Diseases
Neurological Disorders
Endocrine and Metabolic Diseases
Diabetes and Obesity
Cancer and Oncology
Genetic and Rare Diseases
Autoimmune and Inflammatory Diseases
Immunology
Medical Microbiology
Virology
Bacteriology
Parasitology
Clinical Medicine
Internal Medicine
Pediatrics
Geriatric Medicine
Epidemiology
Public Health
Preventive Medicine
Translational Medicine
Precision and Personalized Medicine
Diagnostic Medicine
Molecular Pathology
Pharmacology and Therapeutics
Drug Discovery and Development
Clinical Trials
Vaccines and Immunization
Antimicrobial Resistance
Health Informatics and Artificial Intelligence in Healthcare
Global Health
One Health
Environmental and Occupational Health
Rehabilitation and Palliative Care

The journal also encourages submissions that integrate medicine, biomedical sciences, biotechnology, artificial intelligence, bioinformatics, and public health to address complex disease-related challenges. Manuscripts should demonstrate scientific rigor, methodological soundness, ethical integrity, and the potential to advance medical knowledge and improve healthcare outcomes.

All Articles of Diseases publications are made freely and permanently available online as soon as they are published, without any subscription fees or registration requirements.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Platform Statistics

9+
Active Journals
143+
OA Articles

Article Statistics

40.89% 28.41% 30.09%
Accepted Article 28.41%
Rejected Article 40.89%
Submitted Article 30.09%

Current Issue Highlights

AUTHORS: Aldiouma Guindo1*, Yeya dit Sadio Sarro1, Sekou Kene1, Boubacari Ali Toure1, Abdulmalik Koya1, Ibrahima Keita1, Yaya Coulibaly1, Mody Coulibaly1, Mohamed Ag Baraika1, Moussa Coulibaly1, Mariam Kanta1, Traore Aissata1, Pierre Guindo1, Oumar Tessougue1, Drissa Diabate1, Mounirou Baby1, Emilie Lauressergues2, Veronique Teyssie2, Christophe Przybilski2, Béatrice Garrette2
A Comprehensive Study on the Hematological Progression of Sickle Cell Disease Patients with COVID-19 at the Center for Research and Control of Sickle Cell Disease, Bamako

Associated and indexed with

Partner Partner Partner Partner Partner